← News
Aug 28, 2026 Psychedelics
New on Altitude: Ketamine Has More Patents Than Any Compound We Track — So Why Isn't Big Pharma More Interested?
Ketamine tops our patent tracker at 71 granted patents — more than psilocybin, more than MDMA — and almost all of it traces to one drug, Spravato. We dug into why the compound already approved and already prescribed isn't getting the gold-rush treatment the still-illegal psychedelics are. Read it here.
Read at Altitude